X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
isotopes (166) 166
nanoseconds living radioisotopes (166) 166
nuclei (166) 166
radioisotopes (166) 166
isomeric transition isotopes (152) 152
beta decay radioisotopes (119) 119
light nuclei (101) 101
beta-plus decay radioisotopes (92) 92
odd-odd nuclei (91) 91
stable isotopes (78) 78
intermediate mass nuclei (68) 68
odd-even nuclei (65) 65
years living radioisotopes (64) 64
hours living radioisotopes (63) 63
nuclear physics and radiation physics (62) 62
even-even nuclei (60) 60
beta-minus decay radioisotopes (55) 55
fluorine isotopes (52) 52
fluorine 18 (49) 49
radiology and nuclear medicine (46) 46
diagnostic techniques (45) 45
tomography (45) 45
computerized tomography (44) 44
diseases (44) 44
emission computed tomography (44) 44
positron computed tomography (44) 44
neoplasms (43) 43
radiology (43) 43
fermions (40) 40
medicine (40) 40
nuclear reactions (40) 40
radiotherapy (40) 40
electron capture radioisotopes (39) 39
therapy (39) 39
antimetabolites (38) 38
drugs (38) 38
fluorodeoxyglucose (38) 38
atomic and molecular physics (37) 37
elementary particles (36) 36
nuclear medicine (36) 36
body (35) 35
heavy nuclei (35) 35
humans (35) 35
energy levels (34) 34
index medicus (34) 34
radiology, nuclear medicine & medical imaging (33) 33
rubidium isotopes (33) 33
oncology (32) 32
positron-emission tomography - methods (32) 32
alpha decay radioisotopes (31) 31
decay (30) 30
even-odd nuclei (30) 30
female (30) 30
hematology, oncology and palliative medicine (30) 30
male (28) 28
middle aged (28) 28
organs (28) 28
potassium isotopes (28) 28
aged (27) 27
alkaline earth isotopes (26) 26
energy-level transitions (26) 26
radiations (26) 26
seconds living radioisotopes (26) 26
energy range (25) 25
hadrons (25) 25
resonance (25) 25
rubidium 85 (25) 25
baryons (24) 24
nuclear decay (24) 24
nucleons (24) 24
potassium 40 (24) 24
minutes living radioisotopes (23) 23
optics (23) 23
physics, atomic, molecular & chemical (23) 23
cross sections (22) 22
mathematical models (22) 22
radiation (22) 22
angular momentum (21) 21
atoms (21) 21
classical and quantum mechanics, general physics (21) 21
fluorodeoxyglucose f18 (21) 21
particle properties (21) 21
radiopharmaceuticals (21) 21
adult (20) 20
chemotherapy (20) 20
mev range (19) 19
respiratory system (19) 19
rubidium 87 (19) 19
tomography, x-ray computed - methods (19) 19
calculation methods (18) 18
electromagnetic radiation (18) 18
lungs (18) 18
physics, nuclear (18) 18
cancer (17) 17
cat scanning (17) 17
elements (17) 17
emission (17) 17
excitation (17) 17
internal conversion radioisotopes (17) 17
pet imaging (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 4, pp. 1045 - 1055
Purpose To investigate the feasibility of adaptive intensity-modulated radiation therapy (IMRT) using dose painting by numbers (DPBN) for head-and-neck cancer.... 
Radiology | Hematology, Oncology and Palliative Medicine | Dose painting by numbers | Head-and-neck cancer | Rigid image registration | 18F-fluoro-2-deoxy-d-glucose positron emission tomography | Adaptive intensity-modulated radiation therapy | F-fluoro-2-deoxy-d- glucose positron emission tomography | FDG-PET | IMRT | TARGET VOLUMES | PROPOSAL | MODULATED RADIATION-THERAPY | DELINEATION | ANATOMY | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | F-18-fluoro-2-deoxy-D-glucose positron emission tomography | Radiotherapy Dosage | Radiotherapy Planning, Computer-Assisted - methods | Head and Neck Neoplasms - diagnostic imaging | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Tomography, X-Ray Computed - methods | Male | Positron-Emission Tomography - methods | Tumor Burden | Radiotherapy, Intensity-Modulated - adverse effects | Feasibility Studies | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Maximum Tolerated Dose | Algorithms | Female | Fluorodeoxyglucose F18 | Radiopharmaceuticals | Index Medicus | TOMOGRAPHY | HEAD | HOURS LIVING RADIOISOTOPES | EMISSION COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | RADIATION DOSES | MEDICINE | CAT SCANNING | ANTIMETABOLITES | FLUORINE ISOTOPES | THERAPY | NANOSECONDS LIVING RADIOISOTOPES | POSITRON COMPUTED TOMOGRAPHY | DRUGS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | LIGHT NUCLEI | RADIOLOGY | BETA-PLUS DECAY RADIOISOTOPES | DIAGNOSTIC TECHNIQUES | NEOPLASMS | ISOMERIC TRANSITION ISOTOPES | RADIOISOTOPES | TOXICITY | COMPUTERIZED TOMOGRAPHY | NUCLEAR MEDICINE | ISOTOPES | DISEASES | NUCLEI | DOSES | NECK | ODD-ODD NUCLEI | BODY | FLUORINE 18
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 4, pp. 1085 - 1091
Purpose This study aimed to evaluate the toxicity and clinical outcomes for cervical cancer patients treated definitively with intensity-modulated radiation... 
Radiology | Hematology, Oncology and Palliative Medicine | FDG-PET/CT | IMRT | Cervix | Image guidance | Non-IMRT | PELVIC RADIOTHERAPY | LUNG-CANCER | CT | CISPLATIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | HIGH-RISK | OBSERVER VARIATION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | TUMOR VOLUME | Multivariate Analysis | Prospective Studies | Uterine Cervical Neoplasms - radiotherapy | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Tomography, X-Ray Computed - methods | Uterine Cervical Neoplasms - drug therapy | Uterine Cervical Neoplasms - pathology | Positron-Emission Tomography - methods | Radiotherapy, Intensity-Modulated - adverse effects | Disease-Free Survival | Neoplasm Recurrence, Local - diagnostic imaging | Female | Fluorodeoxyglucose F18 | Uterine Cervical Neoplasms - diagnostic imaging | Combined Modality Therapy - methods | Radiopharmaceuticals | Brachytherapy - adverse effects | Index Medicus | TOMOGRAPHY | HOURS LIVING RADIOISOTOPES | EMISSION COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | UROGENITAL SYSTEM DISEASES | MEDICINE | CAT SCANNING | ANTIMETABOLITES | FLUORINE ISOTOPES | THERAPY | NANOSECONDS LIVING RADIOISOTOPES | POSITRON COMPUTED TOMOGRAPHY | DRUGS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | LIGHT NUCLEI | RADIOLOGY | BETA-PLUS DECAY RADIOISOTOPES | DIAGNOSTIC TECHNIQUES | NEOPLASMS | ISOMERIC TRANSITION ISOTOPES | RADIOISOTOPES | COMPUTERIZED TOMOGRAPHY | NUCLEAR MEDICINE | ISOTOPES | DISEASES | NUCLEI | ODD-ODD NUCLEI | BRACHYTHERAPY | FLUORINE 18
Journal Article
Nuclear Data Sheets, ISSN 0090-3752, 2010, Volume 111, Issue 8, pp. 2081 - 2330
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 1, pp. 176 - 184
Purpose Early detection of treatment response in glioma patients after radiochemotherapy (RCX) is uncertain because treatment-related contrast enhancement in... 
Radiology | Hematology, Oncology and Palliative Medicine | Early response | [ 18F]fluoroethyl)-L-tyrosine positron emission tomography | Radiotherapy | Glioblastoma | Radiochemotherapy | F]fluoroethyl)-L-tyrosine positron emission tomography | MGMT PROMOTER METHYLATION | CEREBRAL GLIOMAS | CHEMOTHERAPY | ADJUVANT TEMOZOLOMIDE | RADIATION-THERAPY | BRAIN-TUMORS | MALIGNANT GLIOMA | ONCOLOGY | [F-18]fluoroethyl)-L-tyrosine positron emission tomography | CONFORMAL RADIOTHERAPY | CONCOMITANT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | Prognosis | Prospective Studies | Dacarbazine - therapeutic use | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Male | Tyrosine - analogs & derivatives | Brain Neoplasms - metabolism | Glioblastoma - diagnostic imaging | Dacarbazine - analogs & derivatives | Adult | Female | Glioblastoma - metabolism | Tyrosine - pharmacokinetics | Radiopharmaceuticals - pharmacokinetics | Positron-Emission Tomography - methods | Antineoplastic Agents, Alkylating - therapeutic use | Glioblastoma - therapy | Disease-Free Survival | Magnetic Resonance Imaging | Brain Neoplasms - therapy | Aged | Combined Modality Therapy - methods | Temozolomide | PET imaging | Tracers (Biology) | Gliomas | Radiation | Development and progression | Universities and colleges | TOMOGRAPHY | HOURS LIVING RADIOISOTOPES | EMISSION COMPUTED TOMOGRAPHY | MEDICINE | FLUORINE ISOTOPES | NERVOUS SYSTEM DISEASES | THERAPY | NANOSECONDS LIVING RADIOISOTOPES | TYROSINE | POSITRON COMPUTED TOMOGRAPHY | AMINO ACIDS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | LIGHT NUCLEI | COMBINED THERAPY | GLIOMAS | BETA-PLUS DECAY RADIOISOTOPES | DIAGNOSTIC TECHNIQUES | NEOPLASMS | ISOMERIC TRANSITION ISOTOPES | ORGANIC COMPOUNDS | HYDROXY ACIDS | ORGANIC ACIDS | RADIOISOTOPES | COMPUTERIZED TOMOGRAPHY | ISOTOPES | DISEASES | NUCLEI | UPTAKE | CARBOXYLIC ACIDS | ODD-ODD NUCLEI | FLUORINE 18
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 79, Issue 3, pp. 847 - 852
Purpose Given that proliferating hematopoietic stem cells are especially radiosensitive, the bone marrow is a potential organ at risk, particularly with the... 
Radiology | Hematology, Oncology and Palliative Medicine | Molecular imaging | Bone marrow | Normal tissue toxicity | IMRT | REGENERATION | INTENSITY-MODULATED RADIOTHERAPY | VOLUME | CERVICAL-CANCER | RADIATION | IRRADIATION | GYNECOLOGIC MALIGNANCIES | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Cell Proliferation | Bone Marrow Cells - cytology | Humans | Middle Aged | Male | Positron-Emission Tomography - methods | Dideoxynucleosides | Bone Marrow Cells - diagnostic imaging | Bone and Bones - diagnostic imaging | Organs at Risk - diagnostic imaging | Aged, 80 and over | Adult | Female | Aged | Bone Marrow - diagnostic imaging | Fluorine Radioisotopes | Radiopharmaceuticals | TOMOGRAPHY | HOURS LIVING RADIOISOTOPES | EMISSION COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | BONE MARROW | PROLIFERATION | ANIMAL TISSUES | ANIMAL CELLS | MEDICINE | ANTIMETABOLITES | FLUORINE ISOTOPES | THERAPY | NANOSECONDS LIVING RADIOISOTOPES | POSITRON COMPUTED TOMOGRAPHY | DRUGS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | HEMATOPOIETIC SYSTEM | RADIOTHERAPY | SOMATIC CELLS | LIGHT NUCLEI | RADIOLOGY | BETA-PLUS DECAY RADIOISOTOPES | DISTRIBUTION | DIAGNOSTIC TECHNIQUES | ISOMERIC TRANSITION ISOTOPES | RADIOISOTOPES | TOXICITY | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | ISOTOPES | ORGANS | NUCLEI | STEM CELLS | ODD-ODD NUCLEI | BODY | FLUORINE 18
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 06/2010, Volume 77, Issue 2, pp. 329 - 36
Purpose: To evaluate the results of selective nodal irradiation on basis of F-18-deoxyglucose positron emission tomography (PET) scans in patients with... 
Selective nodal irradiation | STAGE | FDG-PET SCAN | PHASE-II | combined modality treatment | RADIATION | DOSE-ESCALATION | CT | ETOPOSIDE | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | elective nodal irradiation | CONCURRENT CHEMOTHERAPY | INVOLVED-FIELD RADIOTHERAPY | small cell lung cancer | positron emission tomography | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | Radiotherapy Dosage | Lung Neoplasms - drug therapy | Prospective Studies | Mediastinum | Humans | Middle Aged | Carboplatin - administration & dosage | Lung Neoplasms - radiotherapy | Etoposide - administration & dosage | Male | Tomography, X-Ray Computed | Positron-Emission Tomography - methods | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Small Cell Lung Carcinoma - diagnostic imaging | Female | Fluorodeoxyglucose F18 | Lung Neoplasms - diagnostic imaging | Combined Modality Therapy - methods | Radiopharmaceuticals | Lymphatic Irradiation - methods | Radiotherapy, Conformal - methods | Index Medicus | TOMOGRAPHY | HOURS LIVING RADIOISOTOPES | EMISSION COMPUTED TOMOGRAPHY | LUNGS | FLUORODEOXYGLUCOSE | MEDICINE | LYMPHATIC SYSTEM | CAT SCANNING | ANTIMETABOLITES | FLUORINE ISOTOPES | THERAPY | NANOSECONDS LIVING RADIOISOTOPES | POSITRON COMPUTED TOMOGRAPHY | DRUGS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | LIGHT NUCLEI | RADIOLOGY | BETA-PLUS DECAY RADIOISOTOPES | DIAGNOSTIC TECHNIQUES | NEOPLASMS | LYMPH NODES | ISOMERIC TRANSITION ISOTOPES | RADIOISOTOPES | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | ISOTOPES | ORGANS | SURVIVAL TIME | DISEASES | NUCLEI | RESPIRATORY SYSTEM | ODD-ODD NUCLEI | BODY | FLUORINE 18 | SURVIVAL CURVES
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 75, Issue 5, pp. 1493 - 1500
Purpose To evaluate the safety and efficacy of stereotactic body radiotherapy (SBRT) in previously irradiated patients with squamous cell carcinoma of the head... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck squamous cell carcinoma | Head-and-neck cancer | Reirradiation | PET-CT | Stereotactic body radiotherapy | ONCOLOGY-GROUP | INTERSTITIAL IR-192 | RADIATION-THERAPY | NASOPHARYNGEAL CARCINOMA | POSITRON-EMISSION-TOMOGRAPHY | CANCER-PATIENTS | ONCOLOGY | CONCURRENT CHEMOTHERAPY | LOCAL-CONTROL | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Confidence Intervals | Prospective Studies | Tumor Burden - radiation effects | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Carcinoma, Squamous Cell - surgery | Male | Carcinoma, Squamous Cell - diagnostic imaging | Carcinoma, Squamous Cell - radiotherapy | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Radiosurgery - adverse effects | Carcinoma, Squamous Cell - mortality | Neoplasm Recurrence, Local - diagnostic imaging | Aged, 80 and over | Adult | Female | Radiopharmaceuticals | Radiosurgery - methods | Radiotherapy Dosage | Head and Neck Neoplasms - diagnostic imaging | Positron-Emission Tomography - methods | Remission Induction | Head and Neck Neoplasms - pathology | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Retreatment | Quality of Life | Fluorodeoxyglucose F18 | Radiation Injuries - pathology | Aged | Head and Neck Neoplasms - mortality | Head and Neck Neoplasms - surgery | Clinical trials | Squamous cell carcinoma | Radiotherapy | Radiation | Index Medicus | TOMOGRAPHY | HEAD | HOURS LIVING RADIOISOTOPES | EMISSION COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | RADIATION DOSES | MEDICINE | ANTIMETABOLITES | FLUORINE ISOTOPES | THERAPY | NANOSECONDS LIVING RADIOISOTOPES | POSITRON COMPUTED TOMOGRAPHY | DRUGS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | LIGHT NUCLEI | RADIOLOGY | BETA-PLUS DECAY RADIOISOTOPES | DIAGNOSTIC TECHNIQUES | NEOPLASMS | ISOMERIC TRANSITION ISOTOPES | RADIOISOTOPES | TOXICITY | COMPUTERIZED TOMOGRAPHY | NUCLEAR MEDICINE | ISOTOPES | DISEASES | NUCLEI | DOSES | CARCINOMAS | UPTAKE | NECK | ODD-ODD NUCLEI | BODY | FLUORINE 18
Journal Article
Physical Review Letters, ISSN 0031-9007, 08/2011, Volume 107, Issue 10, p. 103001
Journal Article
Nuclear Data Sheets, ISSN 0090-3752, 2010, Volume 111, Issue 6, pp. 1471 - 1618
This evaluation for A = 113 updates one by J. Blachot, (2005Bl05), published in 
PROTON RADIOACTIVITY | EVEN TIN ISOTOPES | LOW-LYING STATES | COULOMB-EXCITATION | PHYSICS, NUCLEAR | ISOBARIC ANALOG RESONANCES | GAMMA-RAY SPECTROSCOPY | INTRUDER BANDS | ATOMIC MASS EVALUATION | NEUTRON-DEFICIENT TELLURIUM | HALF-LIFE MEASUREMENTS | Nuclear Experiment | Physics | INTERMEDIATE MASS NUCLEI | CADMIUM ISOTOPES | RUTHENIUM 113 | MOLYBDENUM 113 | STABLE ISOTOPES | SILVER ISOTOPES | INTERNAL CONVERSION RADIOISOTOPES | YEARS LIVING RADIOISOTOPES | XENON 113 | TECHNETIUM 113 | BETA DECAY RADIOISOTOPES | TIN 113 | INDIUM ISOTOPES | NUCLEAR DATA COLLECTIONS | TECHNETIUM ISOTOPES | EVALUATION | CADMIUM 113 | TELLURIUM 113 | NIOBIUM ISOTOPES | ODD-EVEN NUCLEI | ISOTOPES | NUCLEAR PHYSICS AND RADIATION PHYSICS | ANTIMONY ISOTOPES | PROTON DECAY RADIOISOTOPES | MICROSECONDS LIVING RADIOISOTOPES | MINUTES LIVING RADIOISOTOPES | XENON ISOTOPES | HOURS LIVING RADIOISOTOPES | NIOBIUM 113 | RUTHENIUM ISOTOPES | RHODIUM ISOTOPES | CROSS SECTIONS | SECONDS LIVING RADIOISOTOPES | NANOSECONDS LIVING RADIOISOTOPES | TELLURIUM ISOTOPES | SILVER 113 | BETA-MINUS DECAY RADIOISOTOPES | MOLYBDENUM ISOTOPES | BETA-PLUS DECAY RADIOISOTOPES | PALLADIUM ISOTOPES | ISOMERIC TRANSITION ISOTOPES | CESIUM 113 | RADIOISOTOPES | MILLISECONDS LIVING RADIOISOTOPES | IODINE 113 | PALLADIUM 113 | INDIUM 113 | ELECTRON CAPTURE RADIOISOTOPES | IODINE ISOTOPES | NUCLEI | CESIUM ISOTOPES | DAYS LIVING RADIOISOTOPES | EVEN-ODD NUCLEI | TIN ISOTOPES | NUCLEAR STRUCTURE | ANTIMONY 113 | RHODIUM 113
Journal Article